Related references
Note: Only part of the references are listed.Platelet Membrane Receptor Proteolysis: Implications for Platelet Function
Jiayu Wu et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: implication for myocardial infarction
Roberto Carnevale et al.
EUROPEAN HEART JOURNAL (2020)
Altered coagulation profile in peripheral artery disease patients
Abdelrahman Zamzam et al.
VASCULAR (2020)
Thrombospondin-1 promotes haemostasis through modulation of cAMP signalling in blood platelets.
Ahmed Aburima et al.
BLOOD (2020)
Comprehensive platelet phenotyping supports the role of platelets in the pathogenesis of acute venous thromboembolism - results from clinical observation studies
Marina Panova-Noeva et al.
EBIOMEDICINE (2020)
Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
Marilena Crescente et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study
Yukiko Matsumura-Nakano et al.
CIRCULATION (2019)
Antithrombotic Agents New Directions in Antithrombotic Therapy
Noel C. Chan et al.
CIRCULATION RESEARCH (2019)
Podoplanin in Inflammation and Cancer
Miguel Quintanilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria
Ulrike Binsker et al.
JOURNAL OF INNATE IMMUNITY (2019)
Plasma C-type lectin-like receptor 2 as a predictor of death and vascular events in patients with acute ischemic stroke
X. Wu et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Soluble CLEC-2 is generated independently of ADAM10 and is increased in plasma in acute coronary syndrome: comparison with soluble GPVI
Osamu Inoue et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Reassessing the Mechanisms of Acute Coronary Syndromes The Vulnerable Plaque and Superficial Erosion
Peter Libby et al.
CIRCULATION RESEARCH (2019)
Functional significance of the platelet immune receptors GPVI and CLEC-2
Julie Rayes et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Prognostic Significance of Plasma CLEC-2 (C-Type Lectin-Like Receptor 2) in Patients With Acute Ischemic Stroke
Xia Zhang et al.
STROKE (2019)
von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke
Frederik Denorme et al.
FRONTIERS IN IMMUNOLOGY (2019)
Stability of thromboxane in blood samples
Helga Helgadottir et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2019)
Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation
Daniel Tarnowski et al.
PLATELETS (2018)
von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications
Paolo Calabro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis
Milka Koupenova et al.
CIRCULATION RESEARCH (2018)
CX(3)CR1/CX(3)CL1 Axis Mediates Platelet- Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis
Elena Furio et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Mechanisms of receptor shedding in platelets
Samantha J. Montague et al.
BLOOD (2018)
Current Status, Time Trends and Outcomes of Combination Therapy With Oral Anticoagulant and Antiplatelet Drug in Patients With Atrial Fibrillation - The Fushimi AF Registry -
Nobutoyo Masunaga et al.
CIRCULATION JOURNAL (2018)
Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation
W. E. Wysokinski et al.
THROMBOSIS RESEARCH (2018)
Integrating platelet and coagulation activation in fibrin clot formation
Frauke Swieringa et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects
Constance C. F. M. J. Baaten et al.
BLOOD ADVANCES (2018)
Thrombosis and platelets: an update
Milka Koupenova et al.
EUROPEAN HEART JOURNAL (2017)
Combined aspirin and anticoagulant therapy in patients with atrial fibrillation
Charlotte H. So et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Relationship between renal function and circulating microparticles, soluble P-selectin and E- selectin levels in atrial fibrillation
Yee Cheng Lau et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Model systems for platelet receptor shedding
Markus Bender et al.
PLATELETS (2017)
Taking the stock of granule cargo: Platelet releasate proteomics
Oliver Pagel et al.
PLATELETS (2017)
Regulation of platelet membrane protein shedding in health and disease
Amanda E. Au et al.
PLATELETS (2017)
von Willebrand factor and inflammation
C. Kawecki et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation
B. Steppich et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis
John R. Stack et al.
PLOS ONE (2017)
Fibrin and D-dimer bind to monomeric GPVI
Marie-Blanche Onselaer et al.
BLOOD ADVANCES (2017)
Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice
Sumith R. Panicker et al.
BLOOD (2017)
Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis
Holly Payne et al.
BLOOD (2017)
Association of platelet activation markers with cancer-associated venous thromboembolism
Julia Riedl et al.
PLATELETS (2016)
Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases
Anke Liepelt et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding
Pasquale Pignatelli et al.
PHARMACOLOGICAL RESEARCH (2016)
Platelets as Biomarkers of Coronary Artery Disease
Leonardo Pasalic et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
The Role of Platelets in Venous Thromboembolism
Silvia Montoro-Garcia et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2016)
Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis
Thomas Gremmel et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Haemodiafiltration elicits less platelet activation compared to haemodialysis
Gergely Becs et al.
BMC NEPHROLOGY (2016)
Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease
Nima Ghasemzadeh et al.
ATHEROSCLEROSIS (2015)
SDF-1 alpha is a novel autocrine activator of platelets operating through its receptor CXCR4
Tony G. Walsh et al.
CELLULAR SIGNALLING (2015)
Interaction of von Willebrand factor with platelets and the vessel wall
Z. M. Ruggeri et al.
HAMOSTASEOLOGIE (2015)
Platelet secretory behaviour: as diverse as the granules ... or not?
H. Heijnen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression
Na Wu et al.
PLOS ONE (2015)
Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization
Thomas Gremmel et al.
PLOS ONE (2015)
Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase
Yuko Iida et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)
Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7
M. Chatterjee et al.
CELL DEATH & DISEASE (2015)
Platelets and Their Interactions with Other Immune Cells
Fong W. Lam et al.
COMPREHENSIVE PHYSIOLOGY (2015)
Stromal Cell-Derived Factor 1 as a Biomarker of Heart Failure and Mortality Risk
Subha Subramanian et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Supporting Roles of Platelet Thrombospondin-1 and CD36 in Thrombus Formation on Collagen
Marijke J. E. Kuijpers et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
CLEC-2 expression is maintained on activated platelets and on platelet microparticles
Eelo Gitz et al.
BLOOD (2014)
Emerging roles for platelets as immune and inflammatory cells
Craig N. Morrell et al.
BLOOD (2014)
Aspirin for the Prevention of Recurrent Venous Thromboembolism The INSPIRE Collaboration
John Simes et al.
CIRCULATION (2014)
The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
Chaker Aloui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
12-hydroxyeicosatetraenoic acid is associated with variability in aspirin-induced platelet inhibition
Benjamin H. Maskrey et al.
JOURNAL OF INFLAMMATION-LONDON (2014)
Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy
Yoshiki Yamashita et al.
THROMBOSIS RESEARCH (2014)
Platelets: more than a sack of glue
Andrew S. Weyrich
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2014)
The Evaluation of Novel Biomarkers and the Multiple Biomarker Approach in the Prediction of Cardiovascular Disease
Danny J. Eapen et al.
CURRENT CARDIOVASCULAR RISK REPORTS (2014)
Platelet factor 4 mediates vascular smooth muscle cell injury responses
Guanfang Shi et al.
BLOOD (2013)
Soluble P-selectin level correlates with acetylsalicylic acid but not with clopidogrel response in patients with stable coronary artery disease after a percutaneous coronary intervention
Jan Kaufmann et al.
CORONARY ARTERY DISEASE (2013)
Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm
Han S. Lim et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Platelet-derived CXCL12 (SDF-1α): basic mechanisms and clinical implications
M. Chatterjee et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
The organizing principle of the platelet glycoprotein IbIXV complex
R. Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Plasma levels of soluble glycoprotein VI (sGPVI) are associated with ischemic stroke
Thomas Wurster et al.
PLATELETS (2013)
Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis
Eduardo Fuentes Q et al.
PLATELETS (2013)
Association between plasma soluble P-selectin elements and progressive ischemic stroke
Qian Wang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Platelet and Monocyte Activation in Acute Ischemic Stroke-Is There a Correlation With Stroke Etiology?
Tom Oberheiden et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2012)
Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy
Feng Wang et al.
CYTOKINE (2012)
Biomarkers of platelet activation in acute coronary syndromes
Patrizia Ferroni et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Platelet activation in patients with peripheral vascular disease: Reproducibility and comparability of platelet markers
A. Burdess et al.
THROMBOSIS RESEARCH (2012)
Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
Alf-Age R. Pettersen et al.
THROMBOSIS RESEARCH (2012)
Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
Lina Badimon et al.
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE (2012)
A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation
Ruibin Fu et al.
EUROPACE (2011)
Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction
C. Christersson et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Platelet receptor signaling in thrombus formation
David Stegner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
The role of lectins and glycans in platelet clearance
K. M. Hoffmeister
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Soluble Glycoprotein VI Is Raised in the Plasma of Patients With Acute Ischemic Stroke
Mohammad Al-Tamimi et al.
STROKE (2011)
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients
Maria Lukasik et al.
THROMBOSIS RESEARCH (2011)
Serum Platelet Factor 4 Is an Independent Predictor of Survival and Venous Thromboembolism in Patients with Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions
Silvia Riondino et al.
CLINICAL BIOCHEMISTRY (2010)
A mouse knockout library for secreted and transmembrane proteins
Tracy Tang et al.
NATURE BIOTECHNOLOGY (2010)
Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction
Maciej Pastuszczak et al.
THROMBOSIS RESEARCH (2010)
Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease Patients
A. Bleakley Chandler et al.
THROMBOSIS RESEARCH (2010)
Systemic blood coagulation activation in acute coronary syndromes
Anetta Undas et al.
BLOOD (2009)
Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention
Slobodan D. Obradovic et al.
BLOOD COAGULATION & FIBRINOLYSIS (2009)
Effect of the Thromboxane Prostaglandin Receptor Antagonist Terutroban on Arterial Thrombogenesis after Repeated Administration in Patients Treated for the Prevention of Ischemic Stroke
C. Bal Dit Sollier et al.
CEREBROVASCULAR DISEASES (2009)
Biomarkers for Prognostication After Acute Coronary Syndromes New Times and Statistics
Christopher R. deFilippi et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The effects of antiplatelet agents on platelet-leukocyte aggregations in patients with acute cerebral infarction
Yong-Jun Cao et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
Acute Coronary Syndromes: Diagnosis and Management, Part I
Amit Kumar et al.
MAYO CLINIC PROCEEDINGS (2009)
Influence of platelet count on the expression of platelet collagen receptor glycoprotein VI (GPVI) in patients with acute coronary syndrome
Boris Bigalke et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity
Jeremie Sellam et al.
ARTHRITIS RESEARCH & THERAPY (2009)
A comparison of anticoagulation with bivalirudin and provisional GPIlb/Illa inhibition with unfractionated heparin and mandatory GPIlb/Illa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulation
Michael J. Ray et al.
EUROINTERVENTION (2009)
Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation - Relationship to soluble P-selectin, stroke risk factors, and risk factor intervention
Anirban Choudhury et al.
CHEST (2008)
Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation
Hamza Duygu et al.
EUROPACE (2008)
Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease
Christoph Laske et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2008)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study
Paola Patrignani et al.
PHARMACOGENETICS AND GENOMICS (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Association between circulating level of CD40 ligand and angiographic morphologic features indicating high-burden thrombus formation in patients with acute myocardial infarction undergoing primary coronary intervention
Ali A. Youssef et al.
CIRCULATION JOURNAL (2007)
Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation
Domenico Ferro et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Relationship of soluble CD40 ligand to vascular endothelial growth factor, angiopoietins, and tissue factor in atrial fibrillation - A link among platelet activation, angiogenesis, and thrombosis?
Anirban Choudhury et al.
CHEST (2007)
Platelet function monitoring in patients with coronary artery disease
Paul A. Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
PSGL-I regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets
Vandana S. Dole et al.
THROMBOSIS AND HAEMOSTASIS (2007)
P-selectin primes leukocyte integrin activation during inflammation
Hai-Bo Wang et al.
NATURE IMMUNOLOGY (2007)
Prothrombotic markers and early spontaneous recanalization in ST-segment elevation myocardial infarction
Marie-Genevive Huisse et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Platelets, inflammation and atherosclerosis
S. Lindemann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases
E. E. Gardiner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Endothelial dysfunction in patients with spontaneous venous thromboembolism
Rino Migliacci et al.
HAEMATOLOGICA (2007)
Circulating P-selectin and the risk of recurrent venous thromboembolism
Paul A. Kyrle et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation - A comparison of healthy control subjects and disease control subjects in sinus rhythm
Anirban Choudhury et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Platelet activation in acute pulmonary embolism
T. Chung et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Indices of platelet activation and the stability of coronary artery disease
M. D. Linden et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation - Relationship to stroke risk factors, stroke risk stratification schema, and prognosis
Gregory Y. H. Lip et al.
STROKE (2007)
Effects of blood pressure on the prothrombotic risk in 1235 patients with non-valvular atrial fibrillation
George I. Varughese et al.
HEART (2007)
Evidence of hypercoaguability and inflammation in young patients long after acute cerebral ischaemia
Sasa Anzej et al.
THROMBOSIS RESEARCH (2007)
Insights into the platelet releasate
J. A. Coppinger et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Indices of angiogenesis, platelet activation, and endothelial damage/dysfunction in relation to ethnicity and coronary artery disease: Differences in central versus peripheral levels
Rumi J. Jaumdally et al.
ANNALS OF MEDICINE (2007)
Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention
Jin-chuan Yan et al.
ACTA PHARMACOLOGICA SINICA (2007)
Activation of platelet function through G protein-coupled receptors
Stefan Offermanns
CIRCULATION RESEARCH (2006)
The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention
Jin-Chuan Yan et al.
CLINICA CHIMICA ACTA (2006)
Influence of pre-analytical and analytical factors on soluble CD40L measurements
Nerea Varo et al.
CLINICAL SCIENCE (2006)
Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction
Yoshitaka Ohashi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Influence of sample type and storage conditions on soluble CD40 ligand assessment
M Weber et al.
CLINICAL CHEMISTRY (2006)
Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease -: art. no. e1
RR Azar et al.
AMERICAN HEART JOURNAL (2006)
Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease
S Türker et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Effects of omega-3 polyunsaturated fatty acids on plasma indices of thrombogenesis and inflammation in patients post-myocardial infarction
Kaeng W. Lee et al.
THROMBOSIS RESEARCH (2006)
Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases
Wen-Jane Lee et al.
THROMBOSIS RESEARCH (2006)
Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels
KT Tan et al.
DIABETIC MEDICINE (2005)
D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis - A pilot study
JE Rectenwald et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial
JW Eikelboom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
CD40 ligand influences platelet release of reactive oxygen intermediates
S Chakrabarti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis -: Results from the Dallas Heart Study
JA de Lemos et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Platelets: Physiology and biochemistry
K Jurk et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Relation of platelet activation to coronary angiographic severity and collateralization
MT Tan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke
V Wolff et al.
STROKE (2005)
Soluble CD40L in peripheral artery disease - Relationship with disease severity, platelet markers and the effects of angioplasty
AD Blann et al.
THROMBOSIS AND HAEMOSTASIS (2005)
GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention
MI Furman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Platelet microparticles and soluble P selectin in peripheral artery disease: Relationship to extent of disease and platelet activation markers
KT Tan et al.
ANNALS OF MEDICINE (2005)
Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus
O Morel et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Platelets in patients with acute ischemic stroke are exhausted and refractory to thrombin, due to cleavage of the seven-transmembrane thrombin receptor (PAR-I)
K Jurk et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation
DSG Conway et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Platelet morphology, soluble P selectin and platelet P-selectin in acute ischaemic stroke - The West Birmingham Stroke Project
SK Nadar et al.
THROMBOSIS AND HAEMOSTASIS (2004)
Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists
O Morel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase
EE Gardiner et al.
BLOOD (2004)
The emerging value of P-selectin as a disease marker
J Kappelmayer et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation
DSG Conway et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Relation of interleukin-6,C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation
DSG Conway et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Tumor necrosis factor-α-converting enzyme (ADAM17) mediates GPIbα shedding from platelets in vitro and in vivo
W Bergmeier et al.
CIRCULATION RESEARCH (2004)
The adhesion molecule P-selectin and cardiovascular disease
AD Blann et al.
EUROPEAN HEART JOURNAL (2003)
New markers of inflammation and endothelial cell activation - Part I
PE Szmitko et al.
CIRCULATION (2003)
The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease
KSS Prasad et al.
CURRENT OPINION IN HEMATOLOGY (2003)
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes
P Cherian et al.
STROKE (2003)
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation
DSG Conway et al.
CIRCULATION (2003)
Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor
K Jurk et al.
FASEB JOURNAL (2003)
Atrial fibrillation and the prothrombotic state in the elderly - The Rotterdam Study
DSG Conway et al.
STROKE (2003)
Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease
AJ Makin et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Thrombogenesis and endothelial damage/dysfunction in peripheral artery disease: Relationship to ethnicity and disease severity
AJ Makin et al.
THROMBOSIS RESEARCH (2003)
A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy
S Kamath et al.
EUROPEAN HEART JOURNAL (2002)
A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation
S Kamath et al.
BLOOD COAGULATION & FIBRINOLYSIS (2002)
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation
S Kamath et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus
S Nomura et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease
AJ Makin et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project
GYH Lip et al.
BLOOD COAGULATION & FIBRINOLYSIS (2002)
A reliable plasma marker of platelet activation: Does it exist?
D Gurney et al.
AMERICAN JOURNAL OF HEMATOLOGY (2002)
Platelet P-selectin levels in relation to plasma soluble P-selectin and β-thromboglobulin levels in atrial fibrillation
S Kamath et al.
STROKE (2002)
Endothelial markers and adhesion molecules in acute ischemic stroke - sequential change and differences in stroke subtype
K Kozuka et al.
ATHEROSCLEROSIS (2002)
CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism
P Andre et al.
NATURE MEDICINE (2002)
Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease
AD Blann et al.
BRITISH JOURNAL OF RADIOLOGY (2001)
Platelet activation: assessment and quantification
S Kamath et al.
EUROPEAN HEART JOURNAL (2001)
Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease
E Lindmark et al.
THROMBOSIS RESEARCH (2001)
Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation
P Järemo et al.
THROMBOSIS RESEARCH (2000)
Pro-coagulant state resulting from high levels of soluble P-selecain in blood
P André et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy
F Sakamaki et al.
CIRCULATION (2000)
Increased platelet activation and endothelial dysfunction in patients with atrial fibrillation immediately following percutaneous balloon mitral valvuloplasty
IRA Goldsmith et al.
CLINICAL CARDIOLOGY (2000)
A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation
FL Li-Saw-Hee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
The β-thromboglobulins and platelet factor 4:: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation
E Brandt et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Soluble P-selectin in human plasma: Effect of anticoagulant matrix and its levels in patients with cardiovascular disorders
HM Amin et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2000)
Increased soluble P-selectin levels following deep venous thrombosis: cause or effect
AD Blann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
